Lv3
230 积分 2025-12-03 加入
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
2个月前
已完结
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
2个月前
已完结
Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI study
3个月前
已完结
Metabolomic signatures of electroconvulsive therapy in schizophrenia: Mitochondrial energy metabolism and inflammation as therapeutic targets
4个月前
已完结
DTI-based fiber tractography: why not?
4个月前
已完结
Multimorbidity and the Etiology of Schizophrenia
5个月前
已完结
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia
5个月前
已完结
皖公网安备34019202002308
